Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 18, 2024
Porcine
deltacoronavirus
(PDCoV),
a
newly
discovered
intestinal
coronavirus,
has
rapidly
spread
among
pigs
worldwide
and
shown
the
potential
for
cross-species
infection.
However,
interaction
mechanism
between
PDCoV
host’s
antiviral
response
is
still
poorly
understood.
In
this
study,
an
E3
ubiquitin
ligase
FBXW8
was
explored
on
proliferation.
Our
findings
demonstrate
that
infection
increases
expression
of
through
p65-mediated
activation
its
promoter.
We
also
suppresses
replication
by
directly
targeting
inducing
degradation
PDCoV-encoded
nucleocapsid
(N)
protein.
Interestingly,
catalyzes
K48-linked
polyubiquitination
N
protein
at
unique
lysine-rich
region
(KR).
Furthermore,
we
observed
FBXW8-ubiquitinated
interacts
with
NDP52,
cargo
receptor,
leading
to
autophagic
instead
proteasomal
degradation.
summary,
these
reveal
as
novel
host
factor
involved
in
It
mediates
NDP52-dependent
These
results
provide
new
insights
target
defenses
against
PDCoV.
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(2)
Published: Feb. 1, 2024
Abstract
Membrane‐associated
RING‐CH
(MARCH)
family
proteins
were
recently
reported
to
inhibit
viral
replication
through
multiple
modes.
Previous
work
showed
that
human
MARCH8
blocked
Ebola
virus
(EBOV)
glycoprotein
(GP)
maturation.
Our
study
here
demonstrates
MARCH1
and
MARCH2
share
a
similar
pattern
in
restricting
EBOV
GP‐pseudotyped
infection.
Human
retain
GP
at
the
trans
‐Golgi
network,
reduce
its
cell
surface
display,
impair
virions
infectivity.
Furthermore,
we
uncover
host
proprotein
convertase
furin
could
interact
with
MARCH1/2
intracellularly.
Importantly,
P
domain
is
verified
be
recognized
by
MARCH1/2/8,
which
critical
for
their
blocking
activities.
Besides,
bovine
murine
also
proteolytic
processing.
Altogether,
our
findings
confirm
of
different
mammalian
origins
relatively
conserved
feature
cleavage,
provide
clues
subsequent
MARCHs
antiviral
studies
may
facilitate
development
novel
strategies
antagonize
enveloped
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Nov. 1, 2023
Long
COVID
is
a
debilitating
chronic
condition
that
has
affected
over
100
million
people
globally.
It
characterized
by
diverse
array
of
symptoms,
including
fatigue,
cognitive
dysfunction
and
respiratory
problems.
Studies
have
so
far
largely
failed
to
identify
genetic
associations,
the
mechanisms
behind
disease,
or
any
common
pathophysiology
with
other
conditions
such
as
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
present
similar
symptoms.We
used
combinatorial
analysis
approach
combinations
variants
significantly
associated
development
long
examine
biological
underpinning
its
various
symptoms.
We
compared
two
subpopulations
patients
from
Sano
Genetics'
GOLD
study
cohort,
focusing
on
severe
dominant
phenotypes.
evaluated
signatures
previously
identified
in
an
ME/CFS
population
against
this
understand
similarities
disorders
may
be
triggered
prior
viral
infection.
Finally,
we
also
output
known
associations
diseases,
range
metabolic
neurological
disorders,
overlap
pathophysiological
mechanisms.Combinatorial
73
genes
were
highly
at
least
one
populations
included
analysis.
Of
these,
9
acute
COVID-19,
14
differentially
expressed
transcriptomic
patients.
A
pathway
enrichment
revealed
pathways
most
mainly
aligned
cardiometabolic
diseases.
Expanded
genotype
suggests
specific
SNX9
genotypes
are
significant
contributor
risk
protection
infection,
but
gene-disease
relationship
context
dependent
mediated
interactions
KLF15
RYR3.
Comparison
uniquely
Severe
Fatigue
Dominant
differences
between
enriched
each
subgroup.
The
unique
immune
myeloid
differentiation
macrophage
foam
cells.
Genes
subgroup
MAPK/JNK
signaling.
ME/CFS,
several
involved
circadian
rhythm
regulation
insulin
regulation.
Overall,
39
SNPs
can
linked
recent
patient
UK
Biobank.
Among
COVID,
42
potentially
tractable
for
novel
drug
discovery
approaches,
13
these
already
targeted
drugs
clinical
pipelines.
From
example,
TLR4
antagonists
repurposing
candidates
potential
protect
term
impairment
pathology
caused
SARS-CoV-2.
currently
evaluating
targets
use
treating
and/or
ME/CFS.This
demonstrates
power
analytics
stratifying
heterogeneous
complex
diseases
do
not
simple
monogenic
etiologies.
These
results
build
upon
findings
analyses
COVID-19
expect
access
additional
independent,
larger
datasets
will
further
improve
disease
insights
validate
treatment
options
COVID.
Viral
envelope
glycoproteins
are
crucial
for
viral
infections.
In
the
process
of
enveloped
viruses
budding
and
release
from
producer
cells,
presented
on
membrane
surface
as
spikes,
promoting
virus's
next-round
infection
target
cells.
However,
host
cells
evolve
counteracting
mechanisms
in
long-term
virus-host
co-evolutionary
processes.
For
instance,
cell
antiviral
factors
could
potently
suppress
replication
by
targeting
their
through
multiple
channels,
including
intracellular
synthesis,
glycosylation
modification,
assembly
into
virions,
binding
to
receptors.
Recently,
a
group
studies
discovered
that
some
proteins
specifically
recognized
proprotein
convertase
(PC)
furin
blocked
its
cleavage
glycoproteins,
thus
impairing
infectivity.
Here,
this
review,
we
briefly
summarize
several
such
analyze
roles
reducing
aiming
at
providing
insights
future
studies.
Journal of Virology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 16, 2024
ABSTRACT
The
human
papillomavirus
(HPV)
oncoprotein
E7
is
a
relatively
short-lived
protein
required
for
HPV-driven
cancer
development
and
maintenance.
degraded
through
ubiquitination
mediated
by
cullin
1
(CUL1)
the
ubiquitin-conjugating
enzyme
E2
L3
(UBE2L3).
However,
proteins
are
maintained
at
high
levels
in
most
HPV-positive
cells.
A
previous
proteomics
study
has
shown
that
UBE2L3
CUL1
increased
knockdown
of
E3
ubiquitin
ligase
membrane-associated
ring-CH-type
finger
8
(MARCHF8).
We
have
recently
demonstrated
HPV16
upregulates
MARCHF8
expression
keratinocytes
head
neck
(HPV+
HNC)
Here,
we
report
stabilizes
degrading
components
S-phase
kinase-associated
1-CUL1-F-box
complex
HPV+
HNC
found
cells
drastically
decreases
level
while
increasing
levels.
further
revealed
binds
to
ubiquitinates
enhances
protein.
Conversely,
overexpression
suppresses
tumor
growth
vivo
.
Our
findings
suggest
HPV-induced
prevents
degradation
ubiquitinating
proteins.
IMPORTANCE
Since
essential
virus
replication;
HPV
maintain
HPV-infected
can
be
efficiently
ubiquitinated
proteasomes
host
cell.
Mechanistically,
(UBE2L3)
play
an
role
degradation.
show
membrane
(MARCHF8)
induced
E6
blocking
proteasomes.
knockout
restores
expression,
decreasing
inhibiting
proliferation
Additionally,
or
growth.
results
maintains
cell
inducing
MARCHF8,
which
may
critical
tumorigenesis.
Journal of Virology,
Journal Year:
2023,
Volume and Issue:
97(10)
Published: Sept. 29, 2023
Emerging
vaccine-breakthrough
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
variants
highlight
an
urgent
need
for
novel
antiviral
therapies.
Understanding
the
pathogenesis
of
coronaviruses
is
critical
developing
drugs.
Here,
we
demonstrate
that
SARS-CoV-2
N
protein
suppresses
interferon
(IFN)
responses
by
reducing
early
growth
response
gene-1
(EGR1)
expression.
The
overexpression
EGR1
inhibits
replication
promoting
IFN-regulated
expression,
which
interacts
with
and
degrades
via
E3
ubiquitin
ligase
MARCH8
cargo
receptor
NDP52.
mutants
without
activity
are
no
longer
able
to
degrade
proteins,
indicating
proteins
dependent
on
its
activity.
This
study
found
a
immune
evasion
mechanism
utilized
protein,
helpful
understanding
guiding
design
new
prevention
strategies
against
emerging
coronaviruses.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(3), P. 332 - 332
Published: Feb. 22, 2024
The
human
genome
is
estimated
to
encode
more
than
500
proteases
performing
a
wide
range
of
important
physiological
functions.
They
digest
proteins
in
our
food,
determine
the
activity
hormones,
induce
cell
death
and
regulate
blood
clotting,
for
example.
During
viral
infection,
however,
some
can
switch
sides
activate
glycoproteins,
allowing
entry
virions
into
new
target
cells
spread
infection.
To
reduce
unwanted
effects,
multiple
protease
inhibitors
proteolytic
processing
self
non-self
proteins.
This
review
summarizes
current
knowledge
endogenous
inhibitors,
which
are
known
limit
replication
by
interfering
with
activation
glycoproteins.
We
describe
underlying
molecular
mechanisms
highlight
diverse
strategies
virion
infectivity.
also
provide
examples
how
viruses
evade
restriction
imposed
inhibitors.
Finally,
we
briefly
outline
cellular
be
modified
exploited
therapeutic
purposes.
In
summary,
this
aims
summarize
understanding
as
components
immune
response
variety
pathogens.
ACS Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
10(3), P. 879 - 889
Published: Feb. 22, 2024
The
highly
infectious
coronavirus
SARS-CoV-2
relies
on
the
viral
main
protease
(Mpro,
also
known
as
3CLpro
or
Nsp5)
to
proteolytically
process
polyproteins
encoded
by
genome
for
release
of
functional
units
in
host
cells
initiate
replication.
Mpro
interacts
with
proteins
innate
immune
pathways,
such
IRF3
and
STAT1,
suppress
their
activities
facilitate
virus
survival
proliferation.
To
identify
mechanism
regulating
Mpro,
we
screened
various
classes
E3
ubiquitin
ligases
found
that
Parkin
RING-between-RING
family
can
induce
ubiquitination
degradation
cell.
Furthermore,
when
undergo
mitophagy,
PINK1
kinase
activates
enhances
Mpro.
We
elevated
expression
significantly
decreased
replication
virus.
Interestingly,
infection
downregulates
mouse
lung
tissues
compared
healthy
controls.
These
results
suggest
an
antiviral
role
a
ligase
targeting
potential
exploiting
virus–host
interaction
mediated
treat
infection.
PLoS Pathogens,
Journal Year:
2023,
Volume and Issue:
19(9), P. e1011619 - e1011619
Published: Sept. 14, 2023
The
host
cell
membrane-associated
RING-CH
8
protein
(MARCH8),
a
member
of
the
E3
ubiquitin
ligase
family,
regulates
intracellular
turnover
many
transmembrane
proteins
and
shows
potent
antiviral
activities.
Generally,
2
modes
are
performed
by
MARCH8.
On
one
hand,
MARCH8
catalyzes
viral
envelope
glycoproteins
(VEGs)
ubiquitination
thus
leads
to
their
degradation,
which
is
cytoplasmic
tail
(CT)-dependent
(CTD)
mode.
other
traps
VEGs
at
some
compartments
(such
as
trans-Golgi
network,
TGN)
but
without
inducing
tail-independent
(CTI)
mode,
hijacks
furin,
cellular
proprotein
convertase,
block
cleavage.
In
addition,
C-terminal
tyrosine-based
motif
(TBM)
222YxxL225
also
plays
key
role
in
its
CTI
effects.
contrast
potency,
occasionally
hijacked
viruses
bacteria
enhance
invasion,
indicating
duplex
pathogenic
infections.
This
review
summarizes
MARCH8's
roles
how
evade
restriction,
shedding
light
on
novel
therapeutic
avenues.
Journal of Medical Virology,
Journal Year:
2025,
Volume and Issue:
97(1)
Published: Jan. 1, 2025
ABSTRACT
Kaposi's
sarcoma‐associated
herpesvirus
(KSHV)
employs
diverse
mechanisms
to
subvert
host
immune
responses,
contributing
its
infection
and
pathogenicity.
As
an
evasion
strategy,
KSHV
encodes
the
Membrane‐Associated
RING‐CH
(MARCH)‐family
E3
ligases,
K3,
K5,
which
target
remove
several
regulators
from
cell
surface.
In
this
study,
we
investigate
impact
of
K3
K5
on
lymphotoxin
receptor
(LTβR)
ligands,
LTβ
LIGHT,
are
type
II
transmembrane
proteins
function
as
pivotal
mediators
during
virus
infection.
Upon
co‐expression
viral
MARCH
with
LTβR
showed
that
selectively
targeted
LTβ,
but
not
for
downregulation
surface
expression.
Specifically,
ligases
interacted
domain
LTβ.
Intriguingly,
immature
form
whereas
fully
mature
form.
Subsequent
biochemical
analyses
revealed
disrupted
initial
steps
N‐glycosylation
maturation
This
interference
resulted
in
sequestration
within
endoplasmic
reticulum,
impeding
trafficking
plasma
membrane.
Consequently,
K3‐mediated
expression
suppressed
downstream
signaling
pathway.
These
findings
uncover
a
novel
mechanism
by
ligase
inhibits
membrane
pathway
inflammatory
ligand
through
glycosylation
interference,
potentially
evading
LTβR‐mediated
antiviral
immunity.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 23, 2025
Viral
infectious
diseases,
caused
by
numerous
viruses
including
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
influenza
A
virus
(IAV),
enterovirus
(EV),
human
immunodeficiency
(HIV),
hepatitis
B
(HBV),
and
papillomavirus
(HPV),
pose
a
continuous
threat
to
global
health.
As
obligate
parasites,
rely
on
host
cells
replicate,
have
developed
defense
mechanisms
counteract
viral
infection.
Host
restriction
factors
(HRFs)
are
critical
components
of
the
early
antiviral
response.
These
cellular
proteins
inhibit
replication
spread
impeding
essential
steps
in
life
cycle,
such
as
entry,
genome
transcription
replication,
protein
translation,
particle
assembly,
release.
This
review
summarizes
current
understanding
how
with
primary
focus
their
diverse
against
range
viruses,
SARS-CoV-2,
virus,
enteroviruses,
papillomavirus.
In
addition,
we
highlight
crucial
role
these
shaping
host-virus
interactions
discuss
potential
targets
for
drug
development.